Piracetam and metrazol-induced ECoG phenomena
Mares, P.
Activitas Nervosa Superior 31(1): 67-68
1989
ISSN/ISBN: 0001-7604 PMID: 2782008 Document Number: 336166
Document emailed within 1 workday
Related Documents
Bernásková, K.; Mares, P.; Rokyta, R. 1988: Influence of cinromide on metrazol--induced seizures during ontogenesis in rats Physiologia Bohemoslovaca 37(2): 123-130Lampe, D.; Mai, I. 1976: Modification of isoprenaline-induced myocardial necrosis in the rat by means of pre-treatment with cerutil and piracetam Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(15): 602-604
Korányi, L.; Endröczi, E. 1983: Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats Acta Physiologica Hungarica 62(1): 75-83
Jarzabek-Chorzelska, M.; Zarebska, Z.; Wolska, H.; Rzesa, G. 1976: Immunological phenomena induced by UV rays Acta Dermato-Venereologica 56(1): 15-18
Gallo, G.; Clemenzia, G. 1971: Anaerobic phenomena in plants. II. Experimental studies on the relationships between anaerobiosis phenomena and catalase in caryopses of Oryza sativa Rivista di Biologia 64(3): 397-411
Hirose, T. 1985: Cooperative phenomena in the membrane potential of parathyroid cells induced by divalent cations Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 47(10): 673-687
Zouhar, A.; Mares, P.; Brozek, G. 1980: Electrocorticographic activity elicited by metrazol during ontogenesis in rats Archives Internationales de Pharmacodynamie et de Therapie 248(2): 280-288
Crone, N.E. 2000: Functional mapping with ECoG spectral analysis Advances in Neurology 84: 343-351
Janicki, P.K.; Lipkowski, A.W.; Szreniawski, Z. 1986: Effects of new kyotorphin analogs on ECoG pattern in the rat Activitas Nervosa Superior 28(2): 146-148
Liu, Y.; Xia, Y.; Wu, H.; Lai, Y.; Yao, D. 2007: Synchronization analysis of ECoG and EHG from eplieptiform discharges rats Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 24(3): 496-499
Scherer, R.; Graimann, B.; Huggins, J.E.; Levine, S.P.; Pfurtscheller, G. 2003: Frequency component selection for an ECoG-based brain-computer interface Biomedizinische Technik. Biomedical Engineering 48(1-2): 31-36
Quesney, L.F.; Constain, M.; Rasmussen, T.; Stefan, H.; Olivier, A. 1992: How large are frontal lobe epileptogenic zones? EEG, ECoG, and SEEG evidence Advances in Neurology 57: 311-323
Alexander, G.J.; Kopeloff, L.M.; Alexander, R.B. 1981: Metrazol thresholds in inbred and non-inbred audiosensitive mice Neurotoxicology 2(1): 91-95
Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77
Sweeney, C.J. 2006: ECOG: CHAARTED--ChemoHormonal therapy versus androgen ablation randomized trial for extensive disease in prostate cancer Clinical Advances in Hematology and Oncology: H&o 4(8): 588-590
Williams, M.E. 2004: ECOG 4402: randomized phase III-trial comparing two different rituximab dosing regimens for patients with low tumor burden indolent non-Hodgkin's lymphoma Current Hematology Reports 3(6): 395-396
Picciòla, G. 1979: Glutamminic derivatives of piracetam Bollettino Chimico Farmaceutico 118(5): 282-285
Klink, F.; Grosspietzsch, R.; von Klitzing, L.; Oberheuser, F. 1979: The protective effect of piracetam during delivery Fortschritte der Medizin 97(46): 2163-2165
Platt, D.; Mühlberg, W.; Rieck, W. 1985: The effect of age on clinical pharmacokinetics of piracetam Arzneimittel-Forschung 35(2): 533-535
Hofmann, N. 1978: Piracetam--a drug for decreasing potency? Die Medizinische Welt 29(26): 1096-1099